Inspire Medical is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea.
Inspire Medical has developed the world’s first fully implanted neurostimulation device approved by the FDA for the treatment of Obstructive Sleep Apnea (OSA).
Inspire Medical was formed in 2007. The company is headquartered in Golden Valley, Minnesota.
The Inspire system uses well-established neurostimulation technologies and incorporates a proprietary algorithm that stimulates key airway muscles based on a patient’s unique breathing patterns. Inspire therapy is designed to reduce OSA severity and improve quality of life for patients living with this challenging condition.
Inspire has multiple additional digital health solutions in development that are aimed at improving patient outcomes and medical practice efficiency. Future versions of the Inspire Sleep app will support clinical data collection, provide earlier insight into patient adherence and outcomes, and share data automatically with the Inspire cloud.
Inspire Medical is backed by Synergy Life Science Partner, Medtronic, Kleiner Perkins, OrbiMed, TGap Ventures and others. The company raised $10.7M in a new round on June 06, 2020. This brings Inspire Medical's total funding to $196.7M to date.